2308 J . Org. Chem., Vol. 67, No. 7, 2002
Novak et al.
photometer (SX.18MW). LC-MS experiments were carried out
on a Bruker ESQUIRE-LC-MS instrument with either EI or
ACPI. Deoxyguanosine was purchased from Fluka.
Kin etics a n d Titr a tion s. Reactions were performed in 20
vol % CH3CN-H2O solutions, µ ) 0.5 (NaClO4) at 20 or 60
°C. At pH e 2.5, HClO4 was used to maintain pH. For all other
solutions buffers of HCO2Na/HCO2H, NaOAc/AcOH, Na2HPO4/
NaH2PO4, and tris/trisH+ were used to maintain pH. Ionic
strength was not maintained for HClO4 solutions in the Ho
range. These solutions were prepared as described in the
literature.20 Initial concentrations of 1a -c or d-G of (1-2) ×
Syn th esis. The syntheses and characterization of 1a -c are
described in the literature.1,2a
N-(Gu a n in -8-yl)-4-a m in obip h en yl (2a ). This material
was obtained by allowing 25 mg (0.058 mmol) of 1a to
decompose in 250 mL of HClO4 solution (µ ) 0.5 M (NaClO4),
20% CH3CN-H2O, 0.316 M HClO4, 20 °C). Compound 1a was
dissolved in 10 mL of water and added in 0.9 mL aliquots to
the HClO4 solution at 10 min intervals. The reaction mixture
was allowed to sit for 100 min after the last addition. The
solution was neutralized with 5% NaHCO3 to pH 6.5 and
extracted with CH2Cl2. The CH2Cl2 extracts were dried over
Na2SO4, and the solvent was evaporated to dryness. The
impurities were removed by triturating the precipitate with
anhydrous ether to give 2a : 1H NMR (200 MHz, CDCl3) δ 8.01
(2H, d, J ) 8.4 Hz), 7.70 (4H, m), 7.44 (3H, m); 13C NMR (50.3
MHz, DMSO-d6) δ 153.8 (C), 151.8 (C), 148.4 (C), 140.0 (C),
139.6 (C), 138.0 (C), 134.9 (C), 129.0 (CH), 127.4 (CH), 127.1
(CH), 126.2 (CH), 120.1 (C), 118.1 (CH); LC-MS (ESI, positive
ion mode), C17H14N6OK (M + K) requires m/e 357.08, found
357.14; LC-MS (ESI, negative ion mode), C17H13N6O (M - H)
requires m/e 317.12, found 317.35; High-resolution MS (ES,
positive), C17H15N6O (M + H) requires m/e 319.1307, found
319.1325.
N -(Gu a n osin -8-yl)-2-a m in o-3-m e t h yl-5-p h e n ylp yr i-
d in e (2b). Compound 2b was obtained by allowing 50 mg of
1b to decompose in 250 mL of HClO4 solution (µ ) 0.5
(NaClO4)), 20% CH3CN-H2O, 0.316 M HClO4, 20 °C) as
described above for 2a . The CH2Cl2 extracts were dried over
Na2SO4, and the solvent was evaporated to dryness. The
impurities were removed by triturating the precipitate with
anhydrous ether to give 2b: 1H NMR (200 MHz, DMSO-d6) δ
13.48 (1H, bs), 8.24 (1H, s), 8.14 (1H, s), 7.80 (2H, bs), 7.67
(1H, d, J ) 6 Hz), 7.44 (4H, m); 13C NMR (75.5 MHz, DMSO-
d6) δ 152.2 (C), 141.5 (CH), 134.4 (C), 130.4 (CH), 129.1 (CH),
128.2 (CH), 127.1 (C), 126.7 (C), 126.0 (CH), 124.8 (C), 122.7
(C), 16.5 (CH3); LC-MS (ESI, positive ion mode), C17H16N7OH
(M + H) requires m/e 334.14, found 334.15; LC-MS (ESI,
negative ion mode), C17H14N7OH (M - H) requires m/e 332.13,
found 332.45.
10-5 M were obtained by injecting 15 µL of ca. (2-4) × 10-3
M
DMF stock solutions into 3.0 mL of the reaction solution that
had been incubated at the appropriate temperature for at least
15 min.
Kinetics were monitored by UV or HPLC methods that have
been described.21 HPLC was performed using C-8 reverse
phase analytical columns with MeOH/H2O eluents buffered
with 0.05 M 1/1 KOAc/HOAc. HPLC peaks were monitored
by UV spectroscopy. Absorbance or HPLC peak area vs time
data were fit to the standard first-order rate equation for kobs
> 2 × 10-6 s-1. For slower reactions initial rates were
determined from the slopes of HPLC peak area vs time data
for 1a -c and d-G for the first 5% of the decomposition. Initial
absorbances for spectrophotometric titrations were determined
by extrapolation to t ) 0 using either a linear extrapolation
or the first-order rate equation.
Wavelengths used in these studies are as follows:
1a
1b
1c
d-G
UV; 308 nm, HPLC; 280 nm
UV; 351 or 280 nm, HPLC; 280 nm
UV; 380 nm, HPLC; 340 nm
UV; 257 nm, HPLC; 280 nm
Ack n ow led gm en t. This work was supported, in
part, by a grant from the American Cancer Society
(RPG-96-078-03-CNE). NMR spectra were obtained on
equipment originally made available through an NSF
grant (CHE-9012532) and subsequently upgraded
through an Ohio Board of Regents Investment Fund
grant. MALDI-TOF and LC-MS mass spectra were
obtained on equipment funded by NSF (CHE-9413529)
and the Ohio Board of Regents Investment Fund,
respectively. The stopped-flow spectrophotometer was
obtained through an NSF equipment grant (CHE-
0076936). High resolution mass spectra were obtained
at the Ohio State University Chemical Instrumentation
Center.
N2-(Gu a n in -8-yl)-2-a m in o-9H-p yr id o[2,3-b]in d ole (2c).
This compound was synthesized by a literature procedure:19
1H NMR (300 MHz, DMSO-d6) δ (1H, s, exchangeable), 11.05
(1H, s, br, exchangeable), 10.73 (1H, s, br, exchangeable), 8.39
(1H, d, J ) 8.4 Hz), 7.99 (1H, d, J ) 7.7 Hz), 7.46 (1H, d, J )
8.0 Hz), 7.33 (1H, t, J ) 8.1 Hz), 7.17 (1H, t, J ) 7.5 Hz), 6.90
(1H, d, J ) 8.4 Hz), 6.33 (2H, s, br, exchangeable); 13C NMR
(75.5 MHz, DMSO-d6) δ 153.0 (3 x C), 152.0 (C), 150.0 (C),
137.6 (C), 131.0 (CH), 124.8 (CH), 121.1 (C), 119.7 (CH), 119.7
(C), 119.6 (CH), 111.1 (CH), 108.6 (C), 103.0 (CH); MALDI-
TOF-MS, C16H13N8O (M + H) requires m/e 333.12, found
333.00.
Su p p or tin g In for m a tion Ava ila ble: Table of rate con-
stants obtained for the hydrolysis of 1a -c and d-G. This
material is available free of charge via the Internet at
http://pubs.acs.org.
J O0163492
(20) Markham, A. E. J . Am. Chem. Soc. 1941, 63, 874-875. Yates,
K.; Wai, H. J . Am. Chem. Soc. 1964, 86, 5408-5413.
(21) Novak, M.; Pelecanou, M.; Roy, A. K.; Andronico, A. F.; Plourde,
F. M.; Olefirowicz, J . M.; Curtin, T. J . J . Am. Chem. Soc. 1984, 106,
5623-5631.
(19) Pfau, W.; Schulze, C.; Shiral, T.; Hasegawa, R.; Brockstedt, U.
Chem. Res. Toxicol. 1997, 10, 1192-1197. Pfau, W.; Brockstedt, U.;
Schulze, C.; Neurath, G.; Marquardt, H. Carcinogenesis 1996, 17,
2727-2732.